U.S. Energy Services Stock News

NYSE:ZIM
NYSE:ZIMShipping

Assessing ZIM Integrated Shipping Services (NYSE:ZIM) Valuation After Earnings Reset And 50% Payout Dividend Decision

Earnings reset and dividend decision put ZIM Integrated Shipping Services (ZIM) in focus ZIM Integrated Shipping Services (ZIM) reported sharply lower quarterly and full year 2025 net income compared with 2024, while its board approved a cash dividend equal to roughly half of annual earnings. The earnings reset, together with a US$106 million fourth quarter dividend and a full year payout of US$1.99 per share, gives investors fresh information to assess the stock’s income profile and recent...
NYSE:ATMU
NYSE:ATMUMachinery

The Bull Case For Atmus Filtration Technologies (ATMU) Could Change Following Strong Earnings Beat And Revenue Surprise – Learn Why

In the recent quarter, Atmus Filtration Technologies, the 2023 Cummins spin-off, reported a 9.8% year-on-year revenue increase and surpassed analyst expectations on both revenue and EBITDA, reflecting strong operational execution across its filtration portfolio. This outperformance suggests that demand for Atmus’ emissions-reducing and engine-protecting filtration solutions is currently running ahead of market assumptions, potentially reshaping how investors assess its earnings profile...
NasdaqGS:FANG
NasdaqGS:FANGOil and Gas

Is It Too Late To Consider Diamondback Energy (FANG) After Strong Multi‑Year Share Gains?

If you are wondering whether Diamondback Energy's current share price still lines up with its underlying worth, the next sections will walk through what the numbers are actually saying about value. The stock last closed at US$189.68, with returns of 7.4% over 7 days, 12.1% over 30 days, 24.5% year to date, 23.6% over 1 year, 65.6% over 3 years, and 215.1% over 5 years. This naturally raises questions about how much of this is already reflected in the valuation. Recent coverage has focused on...
NasdaqGS:BSVN
NasdaqGS:BSVNBanks

Bank7 (BSVN) High 45% Net Margin Softens Narrative Of Fully Stable Earnings

Bank7 (BSVN) FY 2025 earnings snapshot Bank7 (BSVN) has wrapped up FY 2025 with fourth quarter revenue of US$24.1 million and basic EPS of US$1.14, while trailing 12 month revenue came in at US$95.7 million and EPS at US$4.56. Over the past six quarters, revenue has ranged between US$22.6 million and US$24.9 million per quarter as EPS moved between US$1.10 and US$1.26. This gives you a clear line of sight on how the top line and per share profits have tracked into the latest print. With a net...
NasdaqCM:MVST
NasdaqCM:MVSTMachinery

Microvast Holdings (MVST) Is Down 23.6% After Auditor Flags Going Concern Risk Despite Revenue Gains

In March 2026, Microvast Holdings, Inc. reported fourth-quarter 2025 sales of US$96.4 million, full-year sales of US$427.52 million, a sharply lower annual net loss of US$29.22 million, and issued 2026 guidance pointing to continued revenue growth while citing tariff, regulatory, and geopolitical headwinds. On the same day, auditor Deloitte Touche Tohmatsu CPA Ltd issued an unqualified opinion but raised doubt about Microvast’s ability to continue as a going concern, highlighting a tension...
NYSE:GIS
NYSE:GISFood

General Mills (GIS) Margin Compression In Q3 2026 Reinforces Bearish Earnings Narratives

General Mills (GIS) has just posted its Q3 2026 numbers, with revenue at US$4.4b and basic EPS of US$0.57, set against a trailing twelve month EPS of US$4.07 on revenue of US$18.4b. Over recent quarters the company has seen revenue move from US$4.8b in Q2 2026 and US$4.5b in Q1 2026 to the latest US$4.4b print, while basic EPS shifted from US$0.77 and US$2.22 in those periods to US$0.57. This sets up a results season where investors are likely to focus squarely on how margins are holding up...
NasdaqGS:INSM
NasdaqGS:INSMBiotechs

Brinsupri Launch Gives Insmed A New Respiratory Revenue Pillar

Insmed (NasdaqGS:INSM) has launched Brinsupri, also known as brensocatib, for non cystic fibrosis bronchiectasis. Brinsupri is the first approved therapy for this condition and has already generated significant initial sales. The successful launch marks a material commercial milestone for Insmed and adds a new revenue stream alongside its existing portfolio. Insmed focuses on treatments for serious and rare respiratory diseases, so the approval and rollout of Brinsupri fit directly into its...
NasdaqGS:CCEC
NasdaqGS:CCECShipping

A Look At Capital Clean Energy Carriers (CCEC) Valuation After Pivot Toward Gas Assets And Long Term LNG Charters

Capital Clean Energy Carriers (CCEC) recently sold 12 container vessels, raised about US$472.2 million in net proceeds, and redirected that capital into gas transportation assets, including newbuilding LNG carriers on long-term charters. See our latest analysis for Capital Clean Energy Carriers. Despite the recent asset sales and LNG charter wins, the share price is around US$20.21 with a 30 day share price return of about an 11% decline. The 1 year total shareholder return of 5.67% and 3...
NasdaqGS:SCOR
NasdaqGS:SCORMedia

Comscore (SCOR) Q4 Profitability Surge Challenges Multi Year Loss Narrative

comScore FY 2025 earnings snapshot comScore (SCOR) just closed out FY 2025 with Q4 revenue of US$93.5 million and basic EPS of US$12.77, alongside full year trailing twelve month figures showing revenue of US$357.5 million and a net loss of US$101.8 million. Over recent quarters the company has seen revenue move in a narrow band between US$85.7 million and US$94.9 million per quarter. At the same time, basic EPS has swung from a loss of US$12.79 to a profit of US$12.77. This leaves investors...
NYSE:INFQ
NYSE:INFQTech

Infleqtion’s 100 Qubit UK System Puts Neutral Atom Thesis To Test

Infleqtion (NYSE:INFQ) has delivered the UK’s first operational 100-qubit quantum computer to the National Quantum Computing Centre. The system is based on Infleqtion’s Sqale platform and is the only operational 100-physical-qubit quantum computing system currently installed in a UK national facility. This deployment gives UK researchers and industry direct access to larger scale neutral atom hardware for benchmarking and application testing. For investors watching quantum hardware,...
NasdaqGS:PLMR
NasdaqGS:PLMRInsurance

Palomar Revenue Beat Renews Focus On Catastrophe Risk And Valuation

Palomar Holdings (NasdaqGS:PLMR) reported strong fourth quarter results, with revenue figures that were materially ahead of earlier analyst expectations. The quarter highlighted performance in the company’s catastrophe insurance focus, an area closely watched by investors given recent weather and loss events. This update reflects current operating momentum for Palomar’s specialty insurance franchise and has not been widely discussed in recent coverage. Palomar focuses on specialty and...
NasdaqGS:AMRX
NasdaqGS:AMRXPharmaceuticals

A Look At Amneal Pharmaceuticals (AMRX) Valuation After Strong 2025 Results And 2026 Growth Guidance

Amneal Pharmaceuticals (AMRX) is back in focus after reporting 2025 results, with revenue of US$3.02b, operating income of US$421m, and lower net leverage of 3.5x, alongside 2026 guidance pointing to adjusted EBITDA and EPS growth. See our latest analysis for Amneal Pharmaceuticals. The recent pullback, including a 16.4% 1 month share price return decline to US$12.39, sits against a much stronger backdrop. The 1 year total shareholder return is 41.9%, and the 3 year total shareholder return...
NYSE:MCY
NYSE:MCYInsurance

Is It Too Late To Consider Mercury General (MCY) After Its Strong Multi‑Year Rally?

If you are wondering whether Mercury General at around US$87.85 is still offering value or if most of the opportunity has already played out, this overview helps you frame that question clearly. The stock has pulled back with a 0.8% decline over 7 days and a 6.0% decline over 30 days, following very strong returns of 56.5% over 1 year, 216.2% over 3 years and 71.8% over 5 years. Recent attention around the stock has focused on its longer term share price performance and how that compares...
NYSE:VLTO
NYSE:VLTOCommercial Services

A Look At Veralto (VLTO) Valuation After Recent Share Price Weakness

Event context and recent price performance Veralto (VLTO) has been on investors’ radar after recent share price weakness, with the stock down about 11% over the past 3 months and roughly 9% over the past year. See our latest analysis for Veralto. With the share price at $89.99 and a 90 day share price return of 10.7% and 1 year total shareholder return of 8.9%, recent weakness suggests momentum has been fading as investors reassess growth prospects and risk. If this kind of pullback has you...
NasdaqGM:GAMB
NasdaqGM:GAMBMedia

Gambling.com Group (GAMB) Is Down 6.3% After 2025 Loss, Impairment And Buyback-Backed Outlook Shift

In March 2026, Gambling.com Group reported that fourth-quarter 2025 sales rose to US$46.24 million and full-year 2025 sales reached US$165.45 million, but the company swung to a full-year net loss of US$32.93 million after recording a US$14.01 million impairment on intangible assets. Alongside these results, the company completed a share buyback of 3,960,663 shares for US$35.58 million and issued 2026 revenue guidance of US$170 million to US$180 million, highlighting a growing focus on data...
NasdaqGS:CTSH
NasdaqGS:CTSHIT

Is Cognizant (CTSH) Offering Value After A 25.8% Year-To-Date Share Price Decline?

If you are wondering whether Cognizant Technology Solutions at around US$60.29 is a bargain or a value trap, the key is to look closely at what the current price actually implies. The stock has recorded a 3.4% decline over the last 7 days and a 9.4% decline over the last 30 days, contributing to a 25.8% decline year to date and a 23.0% decline over the last year. The 3 year return is 10.4%, and the 5 year return is a 15.2% decline. These moves have put valuation in the spotlight, with...
NYSEAM:PLX
NYSEAM:PLXBiotechs

Protalix BioTherapeutics (PLX) TTM Loss Challenges Bullish Profitability Narratives After FY 2025 Results

Protalix BioTherapeutics FY 2025 Earnings Snapshot Protalix BioTherapeutics (PLX) has wrapped up FY 2025 with fourth quarter revenue of US$9.1 million and a basic EPS loss of US$0.07, as investors weigh the latest numbers against the share price of US$2.21. The company has seen quarterly revenue move from US$18.2 million in Q4 2024 to US$10.1 million in Q1 2025, US$15.7 million in Q2 2025, US$17.9 million in Q3 2025 and US$9.1 million in Q4 2025. Basic EPS shifted from US$0.09 in Q4 2024 to...
NasdaqGM:YB
NasdaqGM:YBInsurance

Yuanbao Group (NasdaqGM:YB) Earnings Put 45.9% Net Margin Narrative In Focus

Yuanbao posted its FY 2025 fourth quarter results with revenue of C¥1.2b and basic EPS of C¥7.49, alongside trailing twelve month EPS of C¥55.72 on revenue of C¥4.4b and net income of C¥2.0b. The company has seen revenue move from C¥888.76m and EPS of C¥11.01 in Q4 2024 to C¥1.2b and C¥7.49 respectively in Q4 2025, set against trailing twelve month earnings growth of 360.7% and an increase in net profit margin from 13.3% to 45.9%. For investors, the latest set of numbers points to a business...
NYSE:HNI
NYSE:HNICommercial Services

HNI’s Hearth Market Role Meets Valuation Gap And Recent Pullback

HNI Corporation, NYSE:HNI, is being highlighted as a major participant in the expanding hearth market. The hearth segment is expected to see substantial growth supported by rising demand and new technology. This attention brings fresh focus to HNI’s hearth business, which has not been a recent focus of coverage. HNI, trading at $35.32, is drawing attention for its role in the hearth market at a time when the shares have seen mixed recent returns. The stock shows a 46.3% gain over the past 3...
NasdaqCM:SGML
NasdaqCM:SGMLMetals and Mining

A Look At Sigma Lithium (SGML) Valuation As Earnings Outlook Softens But Analyst Sentiment Improves

Sigma Lithium (SGML) heads into its March 30, 2026 earnings report with analysts expecting a 50% drop in earnings per share versus last year. However, recent upward estimate revisions suggest shifting sentiment. See our latest analysis for Sigma Lithium. The recent 1-day share price decline of 9.39% to US$10.52 caps a 30-day share price decline of 21.20% and a 1-year total shareholder return decline of 13.27%, hinting that momentum has been fading despite earlier multi year gains. If this...
NasdaqGS:DOCU
NasdaqGS:DOCUSoftware

DocuSign (DOCU) Margin Collapse To 9.6% Tests Long Term Bullish Narratives

DocuSign (DOCU) has just wrapped up FY 2026 with fourth quarter revenue of US$836.9 million and basic EPS of US$0.45, alongside net income excluding extra items of US$90.3 million, putting fresh numbers on the table for investors tracking its earnings story. Over recent periods the company has seen quarterly revenue move from US$776.3 million in FY 2025 Q4 to US$836.9 million in FY 2026 Q4, while basic EPS over the same two quarters has gone from US$0.41 to US$0.45, and trailing 12 month EPS...
NYSE:FTV
NYSE:FTVMachinery

Will Fortive's (FTV) AI-Driven Maintenance and Mapping Tools Reshape Its Industrial Intelligence Narrative

In recent days, Fortive subsidiary Fluke Corporation launched new AI features for its eMaint CMMS/EAM platform and introduced the SmartTrace 2082 Series underground locators integrated with ProStar's PointMan app, enhancing maintenance workflows and underground asset mapping for industrial and infrastructure customers. These upgrades highlight Fortive’s push into AI-enabled maintenance and digital asset intelligence, potentially deepening its role in safety-critical, data-rich industrial...
NasdaqGS:GOSS
NasdaqGS:GOSSBiotechs

Gossamer Bio (GOSS) Quarterly Loss Deepens To US$47 Million Testing Bullish Profitability Narrative

Gossamer Bio (GOSS) has just closed out FY 2025 with fourth quarter revenue of about US$13.8 million and a basic EPS loss of US$0.21, alongside a trailing twelve month EPS loss of US$0.75 on revenue of US$48.5 million. This sets a clear snapshot of where the business stands heading into 2026. Over recent quarters the company has seen revenue move from US$9.4 million in Q4 2024 through US$9.9 million, US$11.5 million and US$13.3 million to US$13.8 million in Q4 2025, while quarterly EPS losses...
NasdaqGS:CDW
NasdaqGS:CDWElectronic

What CDW (CDW)'s Strong Q4 Beat After Share Weakness Means For Shareholders

In the past few days, CDW Corp reported fourth quarter 2025 results that surpassed earnings and revenue forecasts, underlining robust operational execution. What stands out is that this strong quarterly performance comes after a period of prior share price weakness, highlighting a disconnect between recent fundamentals and earlier market sentiment. Next, we'll explore how CDW's stronger-than-expected fourth quarter results might influence its investment narrative built around higher-margin...